Fumaric Acid

Fumaric Acid

SCHEMBL5410033

Cc1ccc(-c2ccc(O[C@H]3CN4CCC3CC4)cc2)cc1N.O=C(O)/C=C/C(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 1/20 0.37
KMT2A known ✓ Q03164 1/20 0.37
CHRNA7 P36544 1/20 0.47
LSS P48449 1/20 0.47
ALDH1A1 P00352 1/20 0.38
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL5410036 1.00 CHRNA7 (0.47) CHRNA7LSSALDH1A1MAPTMEN1
SCHEMBL5408169 0.90 CHRNA7 (0.55) CHRNA7LSS
SCHEMBL5420826 0.90 CHRNA7 (0.55) CHRNA7LSS
Hydrochloric Acid SCHEMBL5430453 0.89 CHRNA7 (0.54) CHRNA7LSSMEN1KMT2A
Fumaric Acid SCHEMBL5430378 0.86 CHRNA7 (0.44) CHRNA7ALDH1A1MAPTMEN1LMNA
Fumaric Acid SCHEMBL5430387 0.86 CHRNA7 (0.44) CHRNA7ALDH1A1MAPTMEN1LMNA
Fumaric Acid SCHEMBL5413575 0.84 LSS (0.47) CHRNA7LSSMAPTMEN1LMNA
Fumaric Acid SCHEMBL5413582 0.84 LSS (0.47) CHRNA7LSSMAPTMEN1LMNA
Fumaric Acid SCHEMBL5417065 0.81 LSS (0.50) CHRNA7LSS
Fumaric Acid SCHEMBL5417070 0.81 LSS (0.50) CHRNA7LSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7309699-B2 3-Quinuclidinyl amino-substituted biaryl derivatives ABBOTT LABORATORIES (US) 2007-12-18 US disclosed
US-20070275975-A1 3-QUINUCLIDINYL AMINO-SUBSTITUTED BIARYL DERIVATIVES JI JIANGUO 2007-11-29 US disclosed
US-20050159597-A1 3-Quinuclidinyl amino-substituted biaryl derivatives ABBOTT LABORATORIES 2005-07-21 US disclosed
US-20050137203-A1 3-quinuclidinyl amino-substituted biaryl derivatives ABBOTT LABORATORIES 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050159597-A1 3-Quinuclidinyl amino-substituted biaryl derivatives CHRNA7, CHRNA9, CHRNA1 MEN1 4420/4885KMT2A 1742/4885CHRNA7 1/4885
US-20070275975-A1 3-QUINUCLIDINYL AMINO-SUBSTITUTED BIARYL DERIVATIVES CHRNA7, CHRNA9, CHRNA1 MEN1 4420/4885KMT2A 1742/4885CHRNA7 1/4885
US-20050137203-A1 3-quinuclidinyl amino-substituted biaryl derivatives CHRNA9, CHRNA7, CHRNA1 MEN1 4549/4885KMT2A 2096/4885CHRNA7 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.